These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32049996)

  • 21. Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel.
    van Leeuwen MAH; van der Hoeven NW; Janssens GN; Everaars H; Nap A; Lemkes JS; de Waard GA; van de Ven PM; van Rossum AC; Ten Cate TJF; Piek JJ; von Birgelen C; Escaned J; Valgimigli M; Diletti R; Riksen NP; van Mieghem NM; Nijveldt R; van Royen N
    Circulation; 2019 Jan; 139(5):636-646. PubMed ID: 30586720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Relative Conditional Survival Estimates on Patient Prognosis After Percutaneous Coronary Intervention.
    Baart SJ; van Domburg RT; Janssen-Heijnen MLG; Deckers JW; Akkerhuis KM; Daemen J; van Geuns RJ; Boersma E; Kardys I
    Circ Cardiovasc Qual Outcomes; 2017 Jun; 10(6):. PubMed ID: 28619724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reperfusion strategy for ST-segment elevation myocardial infarction: trend over a 10-year period.
    Wu KL; Tsui KL; Lee KT; Chau CH; Chan HL; Cheung SH; Cheung CY; Choi MC; Chan KK; Li SK
    Hong Kong Med J; 2012 Aug; 18(4):276-83. PubMed ID: 22865170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction.
    Bonin M; Mewton N; Roubille F; Morel O; Cayla G; Angoulvant D; Elbaz M; Claeys MJ; Garcia-Dorado D; Giraud C; Rioufol G; Jossan C; Ovize M; Guerin P;
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials.
    Dangas GD; Schoos MM; Steg PG; Mehran R; Clemmensen P; van 't Hof A; Prats J; Bernstein D; Deliargyris EN; Stone GW
    Circ Cardiovasc Interv; 2016 May; 9(5):e003272. PubMed ID: 27165710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
    Nikolsky E; Mehran R; Dangas GD; Xu K; Parvataneni R; Witzenbichler B; Guagliumi G; Kornowski R; Généreux P; Brener SJ; Stone GW
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25858976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Velibey Y; Oz A; Tanik O; Guvenc TS; Kalenderoglu K; Gumusdag A; Akdeniz E; Bozbay M; Tekkesin AI; Guzelburc O; Hayiroglu MI; Alper AT; Ugur M; Eren M
    Angiology; 2017 May; 68(5):419-427. PubMed ID: 27473864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.
    Shacham Y; Steinvil A; Arbel Y
    J Nephrol; 2016 Apr; 29(2):169-174. PubMed ID: 26861658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
    Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting).
    Meneveau N; Souteyrand G; Motreff P; Caussin C; Amabile N; Ohlmann P; Morel O; Lefrançois Y; Descotes-Genon V; Silvain J; Braik N; Chopard R; Chatot M; Ecarnot F; Tauzin H; Van Belle E; Belle L; Schiele F
    Circulation; 2016 Sep; 134(13):906-17. PubMed ID: 27573032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment-Elevation Myocardial Infarction: The MIMI Study.
    Belle L; Motreff P; Mangin L; Rangé G; Marcaggi X; Marie A; Ferrier N; Dubreuil O; Zemour G; Souteyrand G; Caussin C; Amabile N; Isaaz K; Dauphin R; Koning R; Robin C; Faurie B; Bonello L; Champin S; Delhaye C; Cuilleret F; Mewton N; Genty C; Viallon M; Bosson JL; Croisille P;
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e003388. PubMed ID: 26957418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry.
    Salinas P; Galeote G; Martin-Reyes R; Perez-Vizcayno MJ; Hernandez-Antolin R; Mainar V; Moreu J; de la Torre JM; Zueco J; Tello A; Jimenez-Valero S; Sanchez-Recalde A; Calvo L; Plaza I; Alfonso F; Mariscal F; Lopez de Sa E; Macaya C; Lopez-Sendon JL; Moreno R
    EuroIntervention; 2011 Apr; 6(9):1080-4. PubMed ID: 21518680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction.
    van de Hoef TP; Bax M; Meuwissen M; Damman P; Delewi R; de Winter RJ; Koch KT; Schotborgh C; Henriques JP; Tijssen JG; Piek JJ
    Circ Cardiovasc Interv; 2013 Jun; 6(3):207-15. PubMed ID: 23735476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.
    Zeller M; Labalette-Bart M; Juliard JM; Potier L; Feldman LJ; Steg PG; Cottin Y; Roussel R
    Int J Cardiol; 2016 Oct; 220():137-42. PubMed ID: 27376570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.